HighGravityDataFMC Corporation — Jul 29, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000037785-26-000139
Showing in the filing
Revenue excluding India (full-year)
“a range of $3.50 billion to $3.70 billion”
Period
FY2026
Measure
GAAP-tied
Source
Prose
All guidance in this release · 35
Revenue excluding India (full-year) for FY2026
“a range of $3.50 billion to $3.70 billion”
Adjusted EBITDA (full-year) for FY2026
“a range of $620 million to $680 million”
Adjusted earnings per diluted share (full-ye… for FY2026
“a range of $1.19 to $1.49”
Free cash flow (full-year) for FY2026
“increased to a range of $75 million to $225 million”
Debt-reduction proceeds target for FY2026
“approximately $1 billion of proceeds”
Proceeds to be used for debt paydown
“approximately $1 billion”
Price (full-year outlook) for FY2026
“expected to be lower by mid-to-high single digits”
Volume excluding India (full-year outlook) for FY2026
“expected to be in line with prior year”
India headwind (full-year outlook) for FY2026
“a 2 percent headwind”
Revenue excluding India for Q3 FY2026
“expected to be in the range of $840 million to $900 million”
Revenue Excl. India for Q3 FY2026
“$840 million to $900 million”
Volume for Q3 FY2026
“expected to be lower”
Adjusted EBITDA for Q3 FY2026
“forecasted to be in the range of $120 million to $140 million”
Adjusted EBITDA for Q3 FY2026
“$120 million to $140 million”
Adjusted earnings per diluted share for Q3 FY2026
“in the range of $0.05 to $0.13”
Adjusted earnings per diluted share for Q3 FY2026
“$0.05 to $0.13”
Revenue excluding India for Q4 FY2026
“expected to be in the range of $1.06 billion to $1.20 billion”
Revenue Excl. India for Q4 FY2026
“$1.06 billion to $1.20 billion”
Volume for Q4 FY2026
“expected to show healthy growth”
Adjusted EBITDA for Q4 FY2026
“forecasted to be in the range of $275 million to $315 million”
Adjusted EBITDA for Q4 FY2026
“$275 million to $315 million”
Adjusted earnings per diluted share for Q4 FY2026
“in the range of $1.09 to $1.33”
Adjusted earnings per diluted share for Q4 FY2026
“$1.09 to $1.33”
Adjusted EPS for Q4 FY2026
“$1.09 to $1.33”
Revenue for FY2026
“$3.50 billion to $3.70 billion”
Revenue Excl. India for FY2026
“$3.50 billion to $3.70 billion”
Growth at midpoint vs. 2025 (Revenue Excl. I… for FY2026
“(7)%”
Growth at midpoint vs. 2025 (Revenue Excl. I… for Q3 FY2026
“(9)%”
Growth at midpoint vs. 2025 (Revenue Excl. I… for Q4 FY2026
“4%”
Growth at midpoint vs. 2025 for Q4 FY2026
“4%”
Adjusted EBITDA for FY2026
“$395 million to $455 million”
Growth at midpoint vs. 2025 for Q3 FY2026
“(45)%”
Adjusted EPS for FY2026
“$1.19 to $1.49”
Adjusted EPS for Q3 FY2026
“$0.05 to $0.13”
Diluted shares assumed for EPS estimates for Q3 FY2026
“125.9 million diluted shares”
Exhibit 99.1 · the passage around this item
… earlier in the release
215.299.6137 Curt.Brooks@fmc.com FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation Updates full-year outlook to reflect more challenging macro environment; Company continues to focus on execution of operational priorities Second Quarter 2026 Highlights • Revenue of $867 million, down 17 percent versus Q2 2025 ◦ Revenue excluding India 1 of $841 million, down 20 percent versus Q2 2025 (which included India) ◦ Organic revenue 2 for the period declined 22 percent • Consolidated GAAP net loss of $187 million, a decline of $253 million versus Q2 2025 • Adjusted EBITDA of $153 million, down 26 percent versus Q2 2025 • Consolidated GAAP net loss of $1.49 per diluted share, down $2.02 versus Q2 2025 • Adjusted earnings per diluted share of $0.26, down 62% versus Q2 2025 • GAAP cash from operations of $363 million, an increase of $297 million versus Q2 2025 Full-Year Outlook 1 • Revenue excluding India lowered to a range of $3.50 billion to $3.70 billion, a decline of 7 percent at the midpoint versus 2025 ◦ Excluding 2025 India contributions, the 2026 outlook represents a decline at the midpoint of 5 percent • Adjusted EBITDA lowered to a range of $620 million to $680 million, a decline of 23 percent at the midpoint • Adjusted earnings per diluted share lowered to a range of $1.19 to $1.49, a decline of 55 percent at the midpoint • Free cash flow, which now includes the upfront licensing payment for rimisoxafen of $200 million, increased to a range of $75 million to $225 million 1 Page 2 / FMC Corporation reports second quarter 2026 results including with Adjusted EBITDA above high end of guidance range and solid cash generation PHILADELPHIA, July 29, 2026 – FMC Corporation (NYSE:FMC) today reported second quarter 2026 revenue of $867 million, down 17 percent versus second quarter 2025. Second quarter 2026 revenue, excluding India, was $841 million, down 20 percent versus second quarter 2025, which included India. On a GAAP basis, the company reported a loss of $1.49 per diluted share in the second quarter, a decrease of $2.02 versus second quarter 2025. Second quarter adjusted earnings per diluted share of $0.26 was down 62 perce
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.